Publication Name	World Journal of Diabetes
Manuscript ID	19786
Country	United Kingdom

Received	2015-05-21 08:42
Peer-Review Started	2015-05-21 17:28
First Decision by Editorial Office Director
Return for Revision	2015-09-17 16:30
Revised	2015-09-25 17:51
Publication Fee Transferred
Second Decision by Editor	2015-10-14 17:30
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2015-10-27 17:34
Articles in Press	2015-10-27 17:34
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-30 08:36
Publish the Manuscript Online	2015-11-11 10:00

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders
Manuscript Source	Invited Manuscript
All Author List	Nigel Irwin and Peter R Flatt
Funding Agency and Grant Number
Corresponding Author	Dr. Nigel Irwin, SAAD Centre for Pharmacy and Diabetes, University of Ulster, Cromore Road, Coleraine BT52 1SA, Northern Ireland, United Kingdom. n.irwin@ulster.ac.uk
Key Words	Diabetes; Obesity; Incretin; Prediabetes; Gut hormones
Core Tip	Stable gut hormones have well defined thera?peutic actions for type 2 diabetes mellitus. In addition, simultaneous modulation of gut hormone receptors could increase therapeutic efficacy, but timing and receptor activation profile may be important. Finally, gut-derived peptides could possess benefits for bone disorders, cognitive impairment and cardiovascular dysfunction.
Publish Date	2015-11-11 10:00
Citation	Irwin N, Flatt PR. New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders. World J Diabetes 2015; 6(15): 1285-1295
URL	http://www.wjgnet.com/1948-9358/full/v6/i15/1285.htm
DOI	http://dx.doi.org/10.4239/wjd.v6.i15.1285

Full Article (PDF)	WJD-6-1285.pdf
Full Article (Word)	WJD-6-1285.doc
Manuscript File	19786-Review.doc
Answering Reviewers	19786-Answering reviewers.pdf
Audio Core Tip	19786-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19786-Conflict-of-interest statement.pdf
Copyright License Agreement	19786-Copyright assignment.pdf
Peer-review Report	19786-Peer-review(s).pdf
Scientific Misconduct Check	19786-Scientific misconduct check.pdf
Scientific Editor Work List	19786-Scientific editor work list.pdf